Results 1 to 10 of about 149,933 (301)

A case of metachronous peripheral T-Cell non-Hodgkin lymphoma following chemotherapy for Hodgkin disease successfully treated with brentuximab vedotin. [PDF]

open access: yesClin Case Rep, 2020
Occasionally, non‐Hodgkin lymphomas (NHL) occur simultaneously or subsequently to Hodgkin disease. We report on a case of a woman with Hodgkin lymphoma treated with ABVD, who developed 4 years later T‐cell NHL with both nodal and extranodal involvement ...
Meconi F   +9 more
europepmc   +2 more sources

Hodgkin disease-an ever-evolving therapy. [PDF]

open access: yesRambam Maimonides Med J, 2014
Therapy of Hodgkin lymphoma (HL) is a rapidly changing field due to plenty of currently emerging data. Treatment approaches are currently based on tailoring of therapy in order to achieve a maximal response with minimal toxicity.
Dann EJ.
europepmc   +2 more sources

Immune Thrombocytopenic Purpura Evolving into Hodgkin’s Disease in a Young Boy [PDF]

open access: yesBengal Physician Journal, 2022
Immune thrombocytopenic purpura (ITP) is a common bleeding disorder, and it may be primary (no potential etiologies found) or secondary (underlying associated conditions).
Karimulla Mondal   +4 more
doaj   +1 more source

Classical Hodgkin lymphoma following follicular lymphoma: a case report [PDF]

open access: yesJournal of Yeungnam Medical Science, 2023
The simultaneous, composite, or sequential occurrence of follicular lymphoma (FL) and classical Hodgkin lymphoma (HL), both of which originate from germinal center B-cell, is rare.
Bomi Kim
doaj   +1 more source

Impact of Cox2, CD163, and Microvessel Density Expression on the Prediction of Relapse and Patients’ Outcome in Classical Hodgkin Lymphoma [PDF]

open access: yesMiddle East Journal of Cancer, 2022
Background: Tumor microenvironment, specifically tumor-associated macrophages, plays an important role in tumor initiation and progression. CD163 has been recognized as a valuable specific macrophage marker.
Rania Makboul   +6 more
doaj   +1 more source

Post-translational proteomics platform identifies neurite outgrowth impairments in Parkinson’s disease GBA-N370S dopamine neurons

open access: yesCell Reports, 2023
Summary: Variants at the GBA locus, encoding glucocerebrosidase, are the strongest common genetic risk factor for Parkinson’s disease (PD). To understand GBA-related disease mechanisms, we use a multi-part-enrichment proteomics and post-translational ...
Helle Bogetofte   +22 more
doaj   +1 more source

Digital Clubbing and Hodgkin Disease in Children: A Case Report and Review of Literature

open access: yesJournal of Pediatrics Review, 2021
Introduction: Digital clubbing (hypertrophic osteoarthropathy) as the initial presentation of lymphoma is rarely reported, particularly in children. In this study, we report a patient with intrathoracic Hodgkin Disease (HD) and digital clubbing as the ...
Hossein Karami   +6 more
doaj   +1 more source

Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma. [PDF]

open access: yes, 2020
Introduction: the high cure rates achieved in early-stage (ES) Hodgkin lymphoma (HL) are one of the great successes of hemato-oncology, but late treatment-related toxicity undermines long-term survival.
Barrington, SF   +11 more
core   +3 more sources

Tuberculous Adenitis with Concurrent Hodgkin Lymphoma: A Case Report

open access: yesOman Medical Journal, 2020
The concomitant occurrence of tuberculous adenitis and Hodgkin lymphoma is rare, posing a diagnostic dilemma since both have similar symptoms, such as lymphadenopathy, weight loss, fever, and night sweats.
Fahmi Yousef Khan   +4 more
doaj   +1 more source

Eosinophilia as a first sign of Hodgkin´s lymphoma: A case report [PDF]

open access: yesVojnosanitetski Pregled, 2017
Introduction. It is well known that eosinophilia appears in a malignant disease. Frequency of all Hodgkin`s lymphoma patients is estimated to about 15%. Prognostic importance of this phenomenon is not completely investigated.
Milošević Rajko   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy